These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15725552)

  • 1. PLA-PEG particles as nasal protein carriers: the influence of the particle size.
    Vila A; Sánchez A; Evora C; Soriano I; McCallion O; Alonso MJ
    Int J Pharm; 2005 Mar; 292(1-2):43-52. PubMed ID: 15725552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration.
    Tobío M; Gref R; Sánchez A; Langer R; Alonso MJ
    Pharm Res; 1998 Feb; 15(2):270-5. PubMed ID: 9523314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-PLA nanoparticles as carriers for nasal vaccine delivery.
    Vila A; Sánchez A; Evora C; Soriano I; Vila Jato JL; Alonso MJ
    J Aerosol Med; 2004; 17(2):174-85. PubMed ID: 15294069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
    Vila A; Gill H; McCallion O; Alonso MJ
    J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
    Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
    Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
    Jain AK; Goyal AK; Mishra N; Vaidya B; Mangal S; Vyas SP
    Int J Pharm; 2010 Mar; 387(1-2):253-62. PubMed ID: 20005936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.
    Yoncheva K; Guembe L; Campanero MA; Irache JM
    Int J Pharm; 2007 Apr; 334(1-2):156-65. PubMed ID: 17118588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T; Bommana MM; Squillante E
    Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
    Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats.
    Zhang QZ; Zha LS; Zhang Y; Jiang WM; Lu W; Shi ZQ; Jiang XG; Fu SK
    J Drug Target; 2006 Jun; 14(5):281-90. PubMed ID: 16882548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
    Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
    Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of a PLA-PEG block copolymer using a PLA derivative with a formyl terminal group and its application to nanoparticulate formulation.
    Sasatsu M; Onishi H; Machida Y
    Int J Pharm; 2005 Apr; 294(1-2):233-45. PubMed ID: 15814247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats.
    Kaminskas LM; Kota J; McLeod VM; Kelly BD; Karellas P; Porter CJ
    J Control Release; 2009 Dec; 140(2):108-16. PubMed ID: 19686787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
    Mainardes RM; Khalil NM; Gremião MP
    Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.